Parkinson's News Today Breaking News Headlines Today | Ground News

Parkinson's News Today image

News from Parkinson's News Today

See all of Parkinson's News Today news coverage in one place. Discover how Parkinson's News Today’s media bias informs their coverage and compare with thousands of other news outlets.

Overall, we’ve indexed 152 stories from Parkinson's News Today over the past 3 months.

Ground News rates Parkinson's News Today’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Parkinson's News Today’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Parkinson's News Today

Where is Parkinson's News Today located?Parkinson's News Today's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Parkinson's News Today News

Wearables and machine learning predict five-year fall risk in Parkinson’s patients

Parkinson's Disease

Wearables and machine learning predict five-year fall risk in Parkinson’s patients

67% Center coverage: 3 sources

Wearable sensor data combined with machine learning predicts fall risk in Parkinson's patients, enhancing preventive care and clinical outcomes over five years.See the Story

Roche Shares Promising Phase IIb PADOVA Study Results for Prasinezumab in Early-Stage Parkinson’s Disease

Parkinson's Disease

Roche Shares Promising Phase IIb PADOVA Study Results for Prasinezumab in Early-Stage Parkinson’s Disease

Roche Shares Promising Phase IIb PADOVA Study Results for Prasinezumab in Early-Stage Parkinson’s Disease (IN BRIEF) Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed motor progression narrowly missed statistical significance, promising efficacy trends were observed, particularly among participants receiving …See the Story

Association of Life’s Essential 8 with femur osteoporosis among US adults: a cross-sectional study from NHANES

Parkinson's Disease · Turkey

Association of Life’s Essential 8 with femur osteoporosis among US adults: a cross-sectional study from NHANES

Osteoporosis is a significant public health concern characterized by decreased bone mineral density and increased fracture risk, particularly among older adults. Lifestyle factors play a crucial role in bone health, and the American Heart Association’s Life’s Essential 8 score has been associa...See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc